No abstract available
MeSH terms
-
Adenocarcinoma / epidemiology
-
Comorbidity
-
Erlotinib Hydrochloride
-
Humans
-
Lung Neoplasms / epidemiology
-
Male
-
Middle Aged
-
Protein Kinase Inhibitors / therapeutic use*
-
Quinazolines / therapeutic use*
-
Treatment Outcome
Substances
-
Protein Kinase Inhibitors
-
Quinazolines
-
Erlotinib Hydrochloride